Sulbactam plus durlobactam: a new addition to antibacterial therapies Access Viewpoint here: Sulbactam plus durlobactam: a new addition to antibacterial therapies – by Ursula Theuretzbacher Author: Ursula Theuretzbacher Tags: Antimicrobial Viewpoint article, Viewpoint, Phase 4, HAP/VAP, Acinetobacter baumannii, Carbapenems
